References and Notes
<A NAME="RU10306ST-1A">1a</A>
Ezzitouni A.
Russ P.
Marquez VE.
J. Org. Chem.
1997,
62:
4870
<A NAME="RU10306ST-1B">1b</A>
Shin KJ.
Moon HR.
George C.
Marquez VE.
J. Org. Chem.
2000,
65:
2172
<A NAME="RU10306ST-1C">1c</A>
Yoshimura Y.
Moon HR.
Choi Y.
Marquez VE.
J. Org. Chem.
2002,
67:
5938
<A NAME="RU10306ST-1D">1d</A>
Choi Y.
George C.
Comin MJ.
Barchi JJ.
Kim HS.
Jacobsen KA.
Balzarini J.
Mitsuya H.
Boyer PL.
Hughes SH.
Marquez VE.
J. Med. Chem.
2003,
46:
3292
<A NAME="RU10306ST-1E">1e</A>
Comin MJ.
Parrish DA.
Deschamps JR.
Marquez VE.
Org. Lett.
2006,
8:
705
<A NAME="RU10306ST-2A">2a</A>
Marquez VE.
Ezzitouni A.
Russ P.
Siddiqui MA.
Ford H.
Feldman RJ.
Mitsuya H.
George C.
Barchi JJ.
J. Am. Chem. Soc.
1998,
120:
2780
<A NAME="RU10306ST-2B">2b</A>
Marquez VE.
Choi Y.
Comin MJ.
Russ P.
George C.
Huleihel M.
Ben-Kasus T.
Agbaria R.
J. Am. Chem. Soc.
2005,
127:
15145
<A NAME="RU10306ST-3A">3a</A>
Paquette LA.
Seekamp CK.
Kahane AL.
J. Org. Chem.
2003,
68:
8614
<A NAME="RU10306ST-3B">3b</A>
Paquette LA.
Kahane AL.
Seekamp CK.
J. Org. Chem.
2004,
69:
5555
<A NAME="RU10306ST-3C">3c</A>
Paquette LA.
Seekamp CK.
Kahane AL.
Hilmey DG.
Gallucci J.
J. Org. Chem.
2004,
69:
7442
<A NAME="RU10306ST-4">4</A>
Obika S.
Nanbu D.
Hari Y.
Morio K.-i.
In Y.
Ishida T.
Imanishi T.
Tetrahedron Lett.
1997,
38:
8735
<A NAME="RU10306ST-5">5</A>
Singh SK.
Nielsen P.
Koshkin AA.
Wengel J.
Chem. Commun.
1998,
455
<A NAME="RU10306ST-6A">6a</A>
Yoshimura Y.
Sano T.
Matsuda A.
Ueda T.
Chem. Pharm. Bull.
1988,
36:
162
<A NAME="RU10306ST-6B">6b</A>
Yoshimura Y.
Matsuda A.
Ueda T.
Nucleosides Nucleotides
1988,
7:
409
<A NAME="RU10306ST-6C">6c</A>
Yoshimura Y.
Matsuda A.
Ueda T.
Chem. Pharm. Bull.
1989,
37:
660
<A NAME="RU10306ST-6D">6d</A>
Yoshimura Y.
Matsuda A.
Ueda T.
Chem. Pharm. Bull.
1990,
38:
389
<A NAME="RU10306ST-7A">7a</A>
Matsuda A.
Muneyama K.
Nishida T.
Sato T.
Ueda T.
Nucleic Acids Res.
1976,
3:
3349
<A NAME="RU10306ST-7B">7b</A>
Ueda T.
Usui H.
Shuto S.
Inoue H.
Chem. Pharm. Bull.
1984,
32:
3410
<A NAME="RU10306ST-7C">7c</A>
Ueda T.
Shuto S.
Satoh M.
Inoue H.
Nucleosides Nucleotides
1985,
4:
401
<A NAME="RU10306ST-7D">7d</A>
Suzuki Y.
Matsuda A.
Ueda T.
Chem. Pharm. Bull.
1987,
35:
1808 ; and references cited therein
<A NAME="RU10306ST-7E">7e</A>
Yoshimura Y.
Ueda T.
Matsuda A.
Tetrahedron Lett.
1991,
32:
4549
<A NAME="RU10306ST-7F">7f</A>
Yoshimura Y.
Otter BA.
Ueda T.
Matsuda A.
Chem. Pharm. Bull.
1992,
40:
1761
<A NAME="RU10306ST-8A">8a</A>
Ueda T.
Usui H.
Shuto S.
Inoue H.
Chem. Pharm. Bull.
1984,
32:
3410
<A NAME="RU10306ST-8B">8b</A>
Yamagata Y.
Tomita K.
Usui H.
Sano T.
Ueda T.
Chem. Pharm. Bull.
1989,
37:
1971
1,5-Hydrogen-transfer-radical cyclization, see:
<A NAME="RU10306ST-9A">9a</A>
Curran DP.
Kim D.
Liu HT.
Shen W.
J. Am. Chem. Soc.
1988,
110:
5900
<A NAME="RU10306ST-9B">9b</A>
Snieckus V.
Cuevas J.-C.
Sloan CP.
Liu H.
Curran DP.
J. Am. Chem. Soc.
1990,
112:
896
<A NAME="RU10306ST-9C">9c</A>
Kittaka A.
Asakura T.
Kuze T.
Tanaka H.
Yamada N.
Nakamura KT.
Miyasaka T.
J. Am. Chem. Soc.
1999,
64:
7081
<A NAME="RU10306ST-9D">9d</A>
Sha C.-K.
Hsu C.-W.
Chen Y.-T.
Cheng S.-Y.
Tetrahedron Lett.
2000,
41:
9865
<A NAME="RU10306ST-9E">9e</A>
Takasu K.
Ohsato H.
Ihara M.
Org. Lett.
2003,
5:
3017
<A NAME="RU10306ST-9F">9f</A>
Beaufils F.
Dénès F.
Renaud P.
Org. Lett.
2004,
6:
2563
<A NAME="RU10306ST-9G">9g</A>
Sukeda M.
Matsuda A.
Shuto S.
Tetrahedron
2005,
61:
7865
<A NAME="RU10306ST-10A">10a</A>
Mastuda A.
Tezuka M.
Ueda T.
Tetrahedron
1978,
34:
2449
<A NAME="RU10306ST-10B">10b</A>
G ani D.
Johnson AW.
Lappert MF.
J. Chem. Soc., Perkin Trans. 1
1981,
3065
<A NAME="RU10306ST-10C">10c</A>
Flyunt R.
Bazzanini R.
Chatgilialoglu C.
Mulazzani QC.
J. Am. Chem. Soc.
2000,
122:
4225
<A NAME="RU10306ST-10D">10d</A>
Chatgilialoglu C.
Guerra M.
Mulazzani QC.
J. Am. Chem. Soc.
2003,
125:
3839
<A NAME="RU10306ST-10E">10e</A>
Chatgilialoglu C.
Duca M.
Ferreri C.
Guerra M.
Ioele M.
Mulazzani QC.
Strittmatter H.
Giese B.
Chem. Eur. J.
2004,
10:
1249
<A NAME="RU10306ST-10F">10f</A>
Navacchia ML.
Chatgilialoglu C.
Montevecchi PC.
J. Org. Chem.
2006,
71:
4445
<A NAME="RU10306ST-10G">10g</A>
Otter BA.
Falco EA.
Fox JJ.
J. Org. Chem.
1976,
41:
3133
<A NAME="RU10306ST-11">11</A>
Yoshimura Y.
Kumamoto H.
Baba A.
Takeda S.
Tanaka H.
Org. Lett.
2004,
6:
1793
<A NAME="RU10306ST-12">12</A>
Tanaka H.
Hayakawa H.
Obi K.
Miyasaka T.
Tetrahedron Lett.
1985,
26:
6229
<A NAME="RU10306ST-13">13</A>
Tandem 1,6-HT-Radical Cyclization of 5a; Typical Procedure
To a refluxing solution of 5a (2.00 g, 2.97 mmol) in toluene (200 mL) was added slowly a solution of TTMSS (2.29
mL, 7.43 mmol) and AIBN (488 mg, 2.97 mmo) in toluene (30 mL) over 1 h by using a
syringe pump. After the mixture was kept under reflux for 6 h, the solvent was removed
under reduced pressure. The residue was purified by silica gel column chromatography
(10-20% EtOAc in hexane) to give 6a (920 mg, 60%), 4a (370 mg, 24%), and 7a (160 mg, 11%) in order of fractions eluted.
Data for 6a
1H NMR (400 MHz, CDCl3): δ = 7.34 (2 H, d, J = 8.7 Hz), 6.82 (2 H, d, J = 8.2 Hz), 6.04 (1 H, s), 4.91 (1 H, d, J = 14.0 Hz), 4.82 (1 H, d, J = 14.0 Hz), 4.79 (1 H, d, J = 5.8 Hz), 4.49 (1 H, d, J = 5.8 Hz), 4.22 (1 H, d, J = 4.3 Hz), 3.78 (3 H, s), 3.59 (1 H, dd, J = 4.4, 8.3 Hz), 3.08 (1 H, ddd, J = 4.1, 8.7, 12.6 Hz), 2.96 (1 H, dd, J = 4.1, 16.2 Hz), 2.46 (1 H, dd, J = 12.3, 16.2 Hz), 1.50 (3 H, s), 1.33 (3 H, s), 0.90 (9 H, s), 0.13 (3 H, s), 0.10
(3 H, s). 13C NMR (100 MHz, CDCl3): δ = 167.1, 159.0, 151.4, 130.4, 129.5, 113.7, 113.0, 86.7, 83.4, 83.0, 78.0, 69.6,
55.2, 51.4, 43.3, 35.9, 25.9, 25.6, 24.7, 17.7, -4.4, -4.9. HRMS (EI): m/z calcd for C26H38N2O7Si [M+]: 518.2448; found: 518.2444. Anal. Calcd for C26H38N2O7Si: C, 60.21; H, 7.38; N, 5.40. Found C, 60.49; H, 7.49; N, 5.41.
Data for 7a
1H NMR (400 MHz, CDCl3): δ = 7.35 (2 H, d, J = 8.7 Hz), 6.81 (2 H, d, J = 8.7 Hz), 6.10 (1 H, s), 4.89 (1 H, d, J = 14.0 Hz), 4.85 (1 H, d, J = 14.0 Hz), 4.56 (1 H, d, J = 5.8 Hz), 4.54 (1 H, d, J = 5.3 Hz), 4.31 (1 H, d, J = 2.4 Hz), 3.77 (3 H, s), 3.48 (1 H, t, J = 2.9 Hz), 3.39 (1 H, dt, J = 4.0, 10.5 Hz), 2.95 (1 H, dd, J = 11.1, 16.4 Hz), 2.46 (1 H, dd, J = 4.8, 16.9 Hz), 1.51 (3 H, s), 1.31 (3 H, s), 0.91 (9 H, s), 0.13 (3 H, s), 0.10
(3 H, s). 13C NMR (100 MHz, CDCl3): δ = 168.2, 158.9, 152.4, 130.4, 129.6, 113.7, 113.2, 86.9, 84.7, 82.8, 79.3, 65.6,
55.2, 49.2, 43.2, 33.0, 25.8, 25.7, 24.6, 18.1, -4.6, -4.8. HRMS (EI): m/z calcd for C26H38N2O7Si [M+]: 518.2448; found: 518.2435. Anal. Calcd for C26H38N2O7Si: C, 60.21; H, 7.38; N, 5.40. Found C, 60.23; H, 7.56; N, 5.40.
<A NAME="RU10306ST-14">14</A> The stereochemistry of 9a was determined by comparison of 1H NMR spectrum of 2′,3′-O-isopropylidene-6,5′-C-cyclo-5,6-dihydrouridine reported previously:
Sugawara T.
Otter BA.
Ueda T.
Tetrahedron Lett.
1988,
29:
75
<A NAME="RU10306ST-15">15</A>
Otter BA.
Falco EA.
Fox JJ.
J. Org. Chem.
1976,
41:
3133